Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fennec Pharmaceuticals Inc.

6.19
+0.18003.00%
Pre-market: 6.210.0200+0.32%04:29 EDT
Volume:41.70K
Turnover:256.75K
Market Cap:170.81M
PE:-309.50
High:6.27
Open:6.02
Low:5.95
Close:6.01
Loading ...

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last?

Zacks
·
21 Mar

Fennec Pharmaceuticals Full Year 2024 Earnings: US$0.003 loss per share (vs US$0.60 loss in FY 2023)

Simply Wall St.
·
11 Mar

Fennec Pharmaceuticals Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Mar

Fennec Pharmaceuticals Inc (FENC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
11 Mar

Q4 2024 Fennec Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
11 Mar

Fennec Pharmaceuticals Shares Down After 4Q Results

Dow Jones
·
11 Mar

Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?

Benzinga
·
11 Mar

Wedbush Reviews Fennec Pharmaceuticals' Q4

MT Newswires
·
11 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Reuters
·
11 Mar

BUZZ-Fennec Pharma falls on surprise Q4 loss

Reuters
·
10 Mar

Fennec Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
10 Mar

Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain

Simply Wall St.
·
10 Mar

Fennec reports Q4 EPS (6c), consensus (13c)

TIPRANKS
·
10 Mar

Fennec Pharmaceuticals Q4 2024 GAAP EPS $(0.06) Up From $(0.10) YoY, Sales $7.92M Down From $9.73M YoY

Benzinga
·
10 Mar

Fennec Pharmaceuticals Inc Q4 Shr View $0.17 -- Lseg Ibes Data

THOMSON REUTERS
·
10 Mar

Fennec Pharmaceuticals Inc: Qtrly Loss per Share $0.06

THOMSON REUTERS
·
10 Mar

Fennec Pharmaceuticals FY Basic EPS USD 0

THOMSON REUTERS
·
10 Mar

Fennec Pharmaceuticals Inc: Cash and Cash Equivalents Were $26.6 Mln as of Dec 31, 2024

THOMSON REUTERS
·
10 Mar

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
10 Mar

Fennec Pharmaceuticals Inc expected to post earnings of 17 cents a share - Earnings Preview

Reuters
·
07 Mar